Overview

A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

Status:
Recruiting

Trial end date:
2025-01-18

Target enrollment:

Participant gender:

Summary

This study aims to evaluate the efficacy and safety of concurrent chemoradiotherapy based of cisplatin with sintilimab as first-line therapy for patients with advanced oral cavity squamous cell carcinoma.

Phase:

Phase 2

Details

Lead Sponsor:

Xin-Hua Xu

Treatments:

Cisplatin